Yu Yong, Shi Min-hua, Xu Xun, Hu Hua-cheng
Department of Respiratory Medicine, the Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
Zhonghua Jie He He Hu Xi Za Zhi. 2010 Apr;33(4):289-94.
To construct a siRNA lentiviral expressing vector targeting PTN (pleiotrophin) gene in human small cell lung cancer H446 cells and to study the RNAi effect on tumor growth and apoptosis.
Four pairs of small hairpin RNA specific for PTN were designed, synthesized and cloned into the Plvthm vector. The resulting lentiviral vector containing shPTN was confirmed by DNA sequencing named LV-shPTN. 293T cells were co-transfected with LV-shPTN, pRsv-REV, pMDlg-pRRE and pMD2G, then packed and purified slightly to produce lentivirus. After infecting H446 cells with recombinant lentivirus, PTN expression was determined by real-time RT-PCR and Western blot. Finally the selected lentiviral vector was packed and purified with best interference efficiency in large scale and the titer of virus was determined. The packed virus was used to infect H446 cells, and then the experiment was divided to a normal cell group, a negative control group, a PTN interference group, a chemotherapy group and a combined group with RNAi and chemotherapy. The effect on cell growth and apoptosis of H446 cells infected with high titer virus was analyzed using MTT and FCM.
DNA sequencing analysis confirmed that shPTN lentiviral vector was successfully established as expected with interference efficiency as high as 72% and 59% at the mRNA and protein level. The titer of concentrated virus was 1 x 10(8) TU/ml. Compared to normal cells and control group, the cell viability of PTN interference group was decreased. Compared to RNAi group and chemotherapy group alone, the combined group with RNAi and chemotherapy showed less cell viability and a higher apoptotic rate in a concentration independent manner of the virus.
PTN RNAi vector construction and H446 cell transfection effectively reduced the PTN transcription and expression, inhibited the growth and promoted the apoptosis of tumor cells. This method may become a useful therapeutic strategy for small cell lung cancer overexpressing PTN.
构建针对人小细胞肺癌H446细胞中多效生长因子(PTN)基因的siRNA慢病毒表达载体,并研究RNA干扰对肿瘤生长和凋亡的影响。
设计、合成四对针对PTN的小发夹RNA,并克隆至Plvthm载体。通过DNA测序确认所得含shPTN的慢病毒载体,命名为LV-shPTN。将LV-shPTN、pRsv-REV、pMDlg-pRRE和pMD2G共转染293T细胞,然后进行轻度包装和纯化以产生慢病毒。用重组慢病毒感染H446细胞后,通过实时RT-PCR和Western印迹法测定PTN表达。最后,对筛选出的干扰效率最佳的慢病毒载体进行大规模包装和纯化,并测定病毒滴度。用包装好的病毒感染H446细胞,然后将实验分为正常细胞组、阴性对照组、PTN干扰组、化疗组以及RNA干扰与化疗联合组。采用MTT法和流式细胞术分析高滴度病毒感染的H446细胞对细胞生长和凋亡的影响。
DNA测序分析证实成功构建了shPTN慢病毒载体,在mRNA和蛋白质水平的干扰效率分别高达72%和59%。浓缩病毒的滴度为1×10(8) TU/ml。与正常细胞和对照组相比,PTN干扰组的细胞活力降低。与单独的RNA干扰组和化疗组相比,RNA干扰与化疗联合组的细胞活力更低,且在病毒浓度无关的情况下凋亡率更高。
PTN RNA干扰载体的构建及H446细胞转染有效降低了PTN的转录和表达,抑制了肿瘤细胞的生长并促进其凋亡。该方法可能成为治疗PTN过表达的小细胞肺癌的有效策略。